📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review. (2023)

First Author: Manyara AM

Attributed to: Reporting of randomised trials using surrogate outcomes: development of extensions to the CONSORT 2010 and SPIRIT 2013 guidance statements funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jclinepi.2023.06.013

PubMed Identifier: 37380118

Publication URI: http://europepmc.org/abstract/MED/37380118

Type: Journal Article/Review

Volume: 160

Parent Publication: Journal of clinical epidemiology

ISSN: 0895-4356